Pulmonx
Jon Biggs is an experienced finance professional with extensive expertise in cost accounting and financial management across various industries. Since August 2019, Jon has served as Sr. Manager of Cost Accounting and Internal Controls at Pulmonx Corporation. Prior roles include Cost Accounting & Finance Manager at Ultratech, Inc., and Sr. Financial Planning & Analysis and Cost Accounting Manager at Micrel. Jon began their career in finance at Cypress Semiconductor, holding multiple controller positions, including roles focused on New Product Development and Sales & Marketing. Jon's educational background includes a BS in Business with a focus on Finance & Accounting from the University of California, Berkeley, Haas School of Business.
This person is not in any teams
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1